Risk of Recurrence in Surgically Resected Stage I Adenocarcinoma of the Lung: Histopathologic and Immunohistochemical Analysis

被引:14
作者
Cho, Sukki [1 ]
Sung, Sook-Whan [1 ,2 ]
Jheon, Sanghoon [1 ,2 ]
Chung, Jin-Haeng [3 ,4 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Thorac & Cardiovasc Surg, Songnam 463707, Gyeonggi Do, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam 463707, Gyeonggi Do, South Korea
关键词
Lung cancer; Stage I; Adenocarcinoma; Prognostic factors; Recurrence;
D O I
10.1007/s00408-008-9116-4
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Study Objectives Stage I adenocarcinoma of the lung is the most common type of lung cancer. A better understanding of the histopathology and molecular biology of lung cancer might improve the capability to predict the outcome for any individual patient. The purpose of this study was to evaluate several histopathologic and molecular markers in order to assess their prognostic value in stage I adenocarcinoma. Methods Fifty-five patients at the Seoul National University Bundang Hospital were enrolled in the study. Histopathologic factors and molecular markers were selected. Results Multivariate analysis demonstrated that necrosis, lymphatic vessel invasion, E-cadherin, p53, and Ki-67 emerged as independent prognostic factors of recurrence. When patients were grouped according to low or high risk according to the number of factors involved, the difference in disease-free survival between these groups was statistically significant. Conclusions In resected stage I adenocarcinoma, necrosis, lymphatic vessel invasion, E-cadherin, and p53 have been identified as independent predictors of disease-free survival.
引用
收藏
页码:411 / 419
页数:9
相关论文
共 29 条
[21]   Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma -: Histopathologic and immunohistochemical analysis [J].
Poleri, C ;
Morero, JL ;
Nieva, B ;
Vázquez, MF ;
Rodríguez, C ;
de Titto, E ;
Rosenberg, A .
CHEST, 2003, 123 (06) :1858-1867
[22]  
QUINLAN DC, 1992, CANCER RES, V52, P4828
[23]   Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis [J].
Steels, E ;
Paesmans, B ;
Berghmans, T ;
Branle, F ;
Lemaitre, F ;
Mascaux, C ;
Meert, AP ;
Vallot, F ;
Lafitte, JJ ;
Sculier, JP .
EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (04) :705-719
[24]  
Strauss GM, 2006, J CLIN ONCOL, V24, p365S
[25]   MOLECULAR AND PATHOLOGICAL MARKERS IN STAGE-I NON-SMALL-CELL CARCINOMA OF THE LUNG [J].
STRAUSS, GM ;
KWIATKOWSKI, DJ ;
HARPOLE, DH ;
LYNCH, TJ ;
SKARIN, AT ;
SUGARBAKER, DJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1265-1279
[26]  
TAKISE A, 1988, CANCER, V61, P2083, DOI 10.1002/1097-0142(19880515)61:10<2083::AID-CNCR2820611025>3.0.CO
[27]  
2-U
[28]   CANCER RECURRENCE AFTER RESECTION - T1 N0 NON-SMALL CELL LUNG-CANCER [J].
THOMAS, P ;
RUBINSTEIN, L .
ANNALS OF THORACIC SURGERY, 1990, 49 (02) :242-247
[29]  
Travis W., 1999, Histological Typing of Lung and Pleural Tumours